Tou Jin-Fa, Li Min-Ju, Guan Tao, Li Ji-Cheng, Zhu Xiong-Kai, Feng Zhi-Gang
Department of Pediatric Surgery, Children's Hospital, Medical College of Zhejiang University, Hangzhou 310003, Zhejiang Province, China.
World J Gastroenterol. 2006 Feb 21;12(7):1136-9. doi: 10.3748/wjg.v12.i7.1136.
To investigate the genetic relationship between Hirschsprung's disease (HD) and intestinal neuronal dysplasia (IND) in Chinese population.
Peripheral blood samples were obtained from 30 HD patients, 20 IND patients, 18 HD/IND combined patients and 20 normal individuals as control. Genomic DNA was extracted according to standard procedure. Exons 11,13,15,17 of RET proto-oncogene were amplified by polymerase chain reaction (PCR). The mutations of RET proto-oncogene were analyzed by single strand conformational polymorphism (SSCP) and sequencing of the positive amplified products was performed.
Eight germline sequence variants were detected. In HD patients, 2 missense mutations in exon 11 at nucleotide 15165 G-->A (G667S), 2 frameshift mutations in exon 13 at nucleotide 18974 (18974insG), 1 missense mutation in exon 13 at nucleotide 18919 A-->G (K756E) and 1 silent mutation in exon 15 at nucleotide 20692 G-->A(Q916Q) were detected. In HD/IND combined patients, 1 missense mutation in exon 11 at nucleotide 15165 G-->A and 1 silent mutation in exon 13 at nucleotide 18888 T-->G (L745L) were detected. No mutation was found in IND patients and controls.
Mutation of RET proto-oncogene is involved in the etiopathogenesis of HD. The frequency of RET proto-oncogene mutation is quite different between IND and HD in Chinese population. IND is a distinct clinical entity genetically different from HD.
研究中国人群中先天性巨结肠(HD)与肠道神经元发育异常(IND)之间的遗传关系。
采集30例HD患者、20例IND患者、18例HD/IND合并患者的外周血样本,并选取20名正常个体作为对照。按照标准程序提取基因组DNA。采用聚合酶链反应(PCR)扩增RET原癌基因的第11、13、15、17外显子。通过单链构象多态性(SSCP)分析RET原癌基因的突变情况,并对阳性扩增产物进行测序。
检测到8种生殖系序列变异。在HD患者中,检测到第11外显子核苷酸15165处的2个错义突变G→A(G667S)、第13外显子核苷酸18974处的2个移码突变(18974insG)、第13外显子核苷酸18919处的1个错义突变A→G(K756E)以及第15外显子核苷酸20692处的1个沉默突变G→A(Q916Q)。在HD/IND合并患者中,检测到第11外显子核苷酸15165处的1个错义突变G→A以及第13外显子核苷酸18888处的1个沉默突变T→G(L745L)。在IND患者和对照中未发现突变。
RET原癌基因突变参与了HD的发病机制。中国人群中IND与HD的RET原癌基因突变频率存在显著差异。IND是一种在遗传上与HD不同的独特临床实体。